Literature DB >> 950692

Oral methylene blue and the dissolution of renal calculi.

A J Wein, G S Benson, D M Raezer, S G Mulholland.   

Abstract

Oral methylene blue therapy was not effective in dissolving non-obstructive renal calculi in 26 patients but it may prevent new stone formation in patients with metabolically active urolithiasis. The use of methylene blue therapy in combination with other regimens having different mechanisms of stone inhibition is recommended to further improve results.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950692     DOI: 10.1016/s0022-5347(17)58723-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  The effect of pH and urine dilution on the electrophoretic mobility of uric acid crystals.

Authors:  S I Ismail; R Tawashi; Z Ismail
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

2.  Methylene blue as an inhibitor of stone formation.

Authors:  K Ahmed; R Tawashi
Journal:  Urol Res       Date:  1978

Review 3.  Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.

Authors:  Claude M Wischik; Björn O Schelter; Damon J Wischik; John M D Storey; Charles R Harrington
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.